CHG-2024-0249

Facility Change for Raredimab. Formulation Change for Raredimab — routine update. Impacts 4 markets and 3 variations.

Change Number
CHG-2024-0249
Type
Facility Change
Product
Raredimab
Status
Approved
Owner
Aisha Okonkwo
Initiated
2023-06-22
Description

Formulation Change for Raredimab — routine update

Impacted Markets (4)
BR — BrazilCH — SwitzerlandPL — PolandBE — Belgium
Impacted Modules
3.2.S3.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved